Home - Clinical Trials Arena
WEBAligos reports positive data from Phase IIa MASH treatment trial. In the trial, doses ranging from 0.5mg to 0.9mg of ALG-055009 led to notable median relative reductions in liver fat. News.
Most significant clinical trials of 2023
WEBDec 27, 2023 · According to GlobalData’s Pharmaceutical Intelligence Centre, there were 22,338 clinical trials initiated in 2023. The main indication of trials initiated in 2023 was oncology, followed by central …
Features - Clinical Trials Arena
Obesity: Six trials to watch over the next 12 months
Gilead’s lenacapavir: HIV prospects strongest in long …
WEBAug 25, 2021 · Gilead’s lenacapavir will find its strongest niche as a long-acting HIV combination treatment, experts said. Manasi Vaidya August 25, 2021. Gilead announced a collaboration with Merck in March to study …
Analysis - Clinical Trials Arena
WEBAlzheimer’s heterogeneity necessitates diverse enrollment in clinical trials. Clinical trials are the final bridge to cross before a new treatment can reach patients. Though Alzheimer's disease affects individuals….
Anixa announces plans to launch breast cancer vaccine trial
News - Clinical Trials Arena
WEBSanofi’s eyes approval after MS therapy slows disease progression by 31%. Sanofi is eyeing up global regulatory approval for tolebrutinib after releasing positive Phase III data in non-relapsing secondary progressive …
Running clinical trials in 2022: what you need to know
WEBJan 4, 2022 · Forecasting clinical trials in 2022. An exclusive Clinical Trials Arena investigation shows the frequency of decentralised clinical trials will reach new heights in 2022, with a likely 28% jump from last year. This …
Disruption in clinical trials: persistent symptoms in …
WEBMar 31, 2022 · Variation in restarting suspended clinical trials. Clinical Trials Arena’s analysis found that overall, 7% of trials with US sites that were in the recruiting phase during the first quarter of 2020 were at some point …